Analyst Recommendations

JMP Securities analyst issues OUTPERFORM recommendation for AXON on October 31, 2024 06:52AM ET. The previous analyst recommendation was Outperform.AXON was trading at $439 at issue of the...

October 31, 2024   AXON 0.95%

KeyBanc analyst issues OVERWEIGHT recommendation for GTES on October 31, 2024 06:52AM ET. The previous analyst recommendation was Overweight.GTES was trading at $19.3 at issue of the analyst...

October 31, 2024   GTES -4.95%

Morgan Stanley analyst issues OVERWEIGHT recommendation for ABBV on October 31, 2024 06:51AM ET. The previous analyst recommendation was Overweight.ABBV was trading at $201.5 at issue of the...

October 31, 2024   ABBV -0.18%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for TWLO on October 31, 2024 06:50AM ET. The previous analyst recommendation was Equal-Weight.TWLO was trading at $70.57 at issue of the...

October 31, 2024   TWLO 0.13%

Citigroup analyst issues BUY recommendation for NRG on October 31, 2024 06:51AM ET. The previous analyst recommendation was Buy.NRG was trading at $88.45 at issue of the analyst...

October 31, 2024   NRG -5.13%

JMP Securities analyst issues OUTPERFORM recommendation for FVRR on October 31, 2024 06:55AM ET. The previous analyst recommendation was Outperform.FVRR was trading at $29.16 at issue of the...

October 31, 2024   FVRR 1.77%

JMP Securities analyst issues OUTPERFORM recommendation for CVNA on October 31, 2024 06:53AM ET. The previous analyst recommendation was Outperform.CVNA was trading at $207.31 at issue of the...

October 31, 2024   CVNA -3.39%

JMP Securities analyst issues OUTPERFORM recommendation for DASH on October 31, 2024 06:54AM ET. The previous analyst recommendation was Outperform.DASH was trading at $155.25 at issue of the...

October 31, 2024   DASH 3.58%

KeyBanc analyst issues OVERWEIGHT recommendation for PCTY on October 31, 2024 06:53AM ET. The previous analyst recommendation was Overweight.PCTY was trading at $178.16 at issue of the analyst...

October 31, 2024   PCTY 3.07%

Citigroup analyst issues BUY recommendation for BIO on October 31, 2024 06:53AM ET. The previous analyst recommendation was Buy.BIO was trading at $330.58 at issue of the analyst...

October 31, 2024   BIO 0.51%